Back to Agenda
Session 1
Speaker(s)
GVP Module Product – or Population-Specific Considerations III: Pregnant and Breastfeeding Women – Where We Are
Viola Macolic Sarinic, DRSc, MD, MSc
Scientific Officer, European Medicines Agency, Netherlands
COVID-19 Pandemic – Challenges and Lessons Learned
Ulla Wändel Liminga, DrMed, MS, RPh
Scientific Director Pharmacology/Toxicology, Medical Products Agency (MPA), Sweden
EMA Pregnancy Strategy
Corinne de Vries, PhD, MA, MSc
EMA liaison official to the US FDA, European Medicines Agency, Netherlands
IMI Conception Consortium: Optimising Data Collection in Pregnant and Breastfeeding Women
David John Lewis, PhD
Former Head QPPV PRRC Office, Patient Safety & Pharmacovigilance, Novartis Pharma Gmbh, Switzerland
Have an account?